PA
LABU icon

Parallel Advisors’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Parallel Advisors’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$146K Hold
500
– – ﹤0.01% 1470
2026
Q1 		$83K Sell
500
-50
-9% -$8.21K ﹤0.01% 1696
2025
Q4 		$87.7K Sell
550
-580
-51% -$79.6K ﹤0.01% 1542
2025
Q3 		$106K Buy
1,130
+50
+5% +$3.53K ﹤0.01% 1397
2025
Q2 		$61.5K Buy
1,080
+300
+38% +$15.9K ﹤0.01% 1607
2025
Q1 		$47.6K Hold
780
– – ﹤0.01% 1660
2024
Q4 		$70.2K Buy
780
+125
+19% +$14.7K ﹤0.01% 1448
2024
Q3 		$84.3K Sell
655
-445
-40% -$58.1K ﹤0.01% 1350
2024
Q2 		$125K Buy
1,100
+120
+12% +$12.8K ﹤0.01% 1075
2024
Q1 		$130K Sell
980
-775
-44% -$101K ﹤0.01% 1057
2023
Q4 		$214K Buy
1,755
+70
+4% +$5.36K 0.01% 770
2023
Q3 		$128K Buy
1,685
+710
+73% +$72.9K ﹤0.01% 968
2023
Q2 		$115K Buy
+975
New +$122K ﹤0.01% 1011

Other funds holding LABU

TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
EFG
Ethos Financial Group King Of Prussia, Pennsylvania $1.5B AUM 22.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return
VR
Valued Retirements Houston, Texas $111M AUM 29.22% 1-Year Est. Return

Parallel Advisors's LABU Position: Q2 2026 in Review

Parallel Advisors held its Direxion Daily S&P Biotech Bull 3X ETF (LABU) position steady in Q2 2026 at 500 shares worth $146K. The position accounts for ﹤0.01% of the portfolio, ranked #1470.

Parallel Advisors first reported a position in LABU in Q2 2023 and has held it in 13 quarters since. The position peaked at $214K in Q4 2023. 27 funds tracked by Wall St. Rank hold LABU as of Q2 2026.

  • Parallel Advisors held 500 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $146K as of Q2 2026.
  • Parallel Advisors left its Direxion Daily S&P Biotech Bull 3X ETF share count unchanged in Q2 2026.
  • Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #1470 holding.
  • Parallel Advisors first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2023 and has held it in 13 quarters since.
  • Parallel Advisors's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $214K in Q4 2023.
  • 27 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.